Pfizer Makes an Unusual Enemy in $2 Billion Fight Over Unwanted Covid-19 Vaccines

The drugmaker has targeted air-traffic control fees in a dispute with Poland and Romania.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。